In last trading session, Immunic Inc (NASDAQ:IMUX) saw 1.04 million shares changing hands with its beta currently measuring 1.95. Company’s recent per share price level of $1.05 trading at -$0.04 or -3.67% at ring of the bell on the day assigns it a market valuation of $94.59M. That closing price of IMUX’s stock is at a discount of -100.95% from its 52-week high price of $2.11 and is indicating a premium of 12.38% from its 52-week low price of $0.92.

For Immunic Inc (IMUX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.

Immunic Inc (NASDAQ:IMUX) trade information

Upright in the red during last session for losing -3.67%, in the last five days IMUX remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $1.05 price level, adding 8.7% to its value on the day. Immunic Inc’s shares saw a change of 5.00% in year-to-date performance and have moved 10.51% in past 5-day. Immunic Inc (NASDAQ:IMUX) showed a performance of 10.18% in past 30-days.

Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 79.0% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -376.19% in reaching the projected high whereas dropping to the targeted low would mean a loss of -376.19% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 31.12% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 55.09% while estimates for its earnings growth in next 5 years are of 36.51%.

Immunic Inc (NASDAQ:IMUX)’s Major holders

BVF INC/IL is the top institutional holder at IMUX for having 8.9 million shares of worth $9.88 million. And as of 2024-06-30, it was holding 9.15 of the company’s outstanding shares.

The second largest institutional holder is AVIDITY PARTNERS MANAGEMENT LP, which was holding about 8.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.15 of outstanding shares, having a total worth of $9.88 million.